The deteriorating patient in nuclear medicine: anaphylaxis, acute coronary syndrome and hypoglycaemia

Nuclear medicine is often seen as calm, controlled and procedural. Yet deterioration does not wait for the patient to reach a ward, emergency department or arrest team. It may begin after a radiopharmaceutical, contrast agent or adjunct medicine; during stress testing; in a corridor; or in a fasting diabetic patient sitting quietly in the waiting room. The first clinical moments therefore belong to the nuclear medicine team.

This article uses three high risk scenarios – anaphylaxis, acute coronary syndrome and hypoglycaemia – to make one practical argument: we must recognise, escalate and treat. It is not asking radiographers or clinical technologists to practise beyond scope. It is asking them to fulfil what safe scope already requires: look again, undertake a structured assessment, use ABCDE/point-of-care glucose where appropriate, call for help early, act within competence, document clearly and hand over with urgency.

Anaphylaxis illustrates the danger of treating the visible rash while missing airway, breathing or circulation compromise. Acute coronary syndrome shows why a normal-looking first ECG must not override a convincing clinical story. Hypoglycaemia reminds us that the waiting room is still clinical space, especially for fasting diabetic patients who become sweaty, vague, drowsy or slow to respond.

The article closes by arguing that readiness must be designed before crisis occurs: stocked kits, accessible monitoring, clear pathways, emergency medicines policy and short in situ drills. The core message is simple: the first clinical moments may be brief, but they are decisive – and they are yours.

To download and read this article as a pdf please sign up to our newsletter.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.